Factors Affecting Helicobacter Pylori Infection: Diet and Lifestyle Patterns
Determinants of Helicobacter Pylori Infection: Role of Dietary and Lifestyle Patterns - Cross Sectional Study
This cross-sectional observational study aims to determine the prevalence of Helicobacter pylori (H. pylori) infection among Information Technology (IT) professionals working in Hyderabad, India, and to identify dietary, lifestyle, occupational, and clinical factors associated with infection. H. pylori is a common bacterial infection of the stomach and is an important cause of chronic gastritis, peptic ulcer disease, and gastric cancer.
Approximately 1,000 eligible IT professionals will be enrolled from participating IT companies using stratified random sampling. Participants will complete a structured questionnaire covering demographic characteristics, dietary habits, occupational factors, gastrointestinal symptoms, lifestyle factors, medical history, and recent medication use. Active H. pylori infection will be determined using the carbon-14 (C14) urea breath test performed at the workplace under standardized conditions.
The study will estimate the prevalence of H. pylori infection in this occupational group and evaluate whether factors such as outside food consumption, office-delivered meals, restaurant dining, street food intake, work schedules, and lifestyle habits are associated with infection. The findings may help identify modifiable risk factors and contribute to the development of workplace health promotion and preventive strategies for IT professionals.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Descrizione dettagliata
Helicobacter pylori (H. pylori) is a spiral-shaped, gram-negative bacterium that colonizes the gastric mucosa and is one of the most common chronic bacterial infections worldwide. It is recognized by the World Health Organization as a Group I carcinogen because of its established association with gastric adenocarcinoma. Persistent infection is also associated with chronic gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma, and dyspeptic symptoms.
Although the prevalence of H. pylori infection has declined in many countries, it remains an important public health problem in India, where prevalence varies considerably across different regions and populations. Transmission is influenced by environmental, socioeconomic, sanitation, and dietary factors. Recent evidence suggests that occupational lifestyle and eating behaviors may also influence infection risk.
Information Technology (IT) professionals represent a unique occupational group characterized by prolonged working hours, sedentary work, irregular meal timings, frequent reliance on restaurant food, office-delivered meals, food delivery services, and high workplace stress. Despite the large and rapidly growing IT workforce in India, there is limited information regarding the prevalence of H. pylori infection and its associated risk factors in this population.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
The study population will include approximately 1,000 adult Information Technology (IT) professionals employed in participating IT companies in Hyderabad, Telangana, India. Eligible participants will be individuals aged 21 years or older who have been employed in their current organization for at least 6 months and provide written informed consent. The study will evaluate the prevalence of active Helicobacter pylori infection using the C14 urea breath test and assess its association with dietary patterns, lifestyle factors, occupational characteristics, clinical history, and medication use
Descrizione
Inclusion Criteria:
- Age ≥21 years.
- Currently employed as an Information Technology (IT) professional at a participating company in Hyderabad, India.
- Minimum 6 months of employment in the current organization.
- Willing to provide written informed consent for participation.
- Able to understand and complete the study questionnaire.
- Able to comply with fasting requirements (minimum 6 hours) before the C14 urea breath test.
Exclusion Criteria:
- Previous Helicobacter pylori eradication treatment.
- Use of proton pump inhibitors (PPIs) or potassium-competitive acid blockers (PCABs) within 2 weeks before testing.
- Use of antibiotics within 4 weeks before testing.
- Use of bismuth-containing compounds within 4 weeks before testing.
- History of gastric surgery.
- Current pregnancy or lactation.
- Active gastrointestinal bleeding.
- Known gastric malignancy.
- Inability to provide informed consent.
- Any condition that prevents completion of study procedures.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: OTHER
- Prospettive temporali: PROSPECTIVE
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Prevalence of active Helicobacter pylori infection
Lasso di tempo: At the study visit during the 2-month data collection period
|
Prevalence of active Helicobacter pylori infection among IT professionals, determined using the carbon-14 (C14) urea breath test. Infection status will be classified as positive or negative according to the manufacturer's recommended cut-off values. Unit of Measure: Percentage (%) of participants with active H. pylori infection. Measurement Tool: C14 urea breath test. |
At the study visit during the 2-month data collection period
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Association between age and active Helicobacter pylori infection
Lasso di tempo: At the study visit during the 2-month data collection period.
|
Association between participant age, measured in years, and active H. pylori infection status determined using the C14 urea breath test. Age will be assessed using the structured demographic questionnaire. |
At the study visit during the 2-month data collection period.
|
|
Association between sex and active Helicobacter pylori infection
Lasso di tempo: At the study visit during the 2-month data collection period
|
Association between participant sex, recorded as a categorical variable, and active H. pylori infection status determined using the C14 urea breath test. Sex will be recorded using the structured demographic questionnaire. |
At the study visit during the 2-month data collection period
|
|
Association between marital status and active Helicobacter pylori infection
Lasso di tempo: At the study visit during the 2-month data collection period
|
Association between marital status, recorded as a categorical variable, and active H. pylori infection status determined using the C14 urea breath test. Marital status will be assessed using the structured demographic questionnaire |
At the study visit during the 2-month data collection period
|
|
Association between daily working hours and active Helicobacter pylori infection
Lasso di tempo: At the study visit during the 2-month data collection period
|
Association between average daily working hours, measured in hours per day, and active H. pylori infection status determined using the C14 urea breath test. Daily working hours will be assessed using the structured occupational questionnaire |
At the study visit during the 2-month data collection period
|
|
Association between frequency of outside-food consumption and active Helicobacter pylori infection
Lasso di tempo: At the study visit during the 2-month data collection period
|
Association between frequency of outside-food consumption, measured in times per week, and active H. pylori infection status determined using the C14 urea breath test. Outside-food consumption will be assessed using the structured dietary questionnaire. |
At the study visit during the 2-month data collection period
|
|
Association between office-tiffin consumption and active Helicobacter pylori infection
Lasso di tempo: At the study visit during the 2-month data collection period
|
Association between office-tiffin consumption, recorded as yes/no, and active H. pylori infection status determined using the C14 urea breath test. Frequency of office-tiffin consumption will additionally be recorded in times per week using the structured dietary questionnaire |
At the study visit during the 2-month data collection period
|
|
Association between smoking status and active Helicobacter pylori infection
Lasso di tempo: At the study visit during the 2-month data collection period
|
Association between smoking status, categorized as never, former, or current smoker, and active H. pylori infection status determined using the C14 urea breath test. Smoking status will be assessed using the structured lifestyle questionnaire |
At the study visit during the 2-month data collection period
|
|
Association between alcohol consumption and active Helicobacter pylori infection
Lasso di tempo: At the study visit during the 2-month data collection period
|
Association between alcohol consumption frequency, measured in times per week, and active H. pylori infection status determined using the C14 urea breath test. Alcohol consumption will be assessed using the structured lifestyle questionnaire |
At the study visit during the 2-month data collection period
|
|
Association between caffeine consumption and active Helicobacter pylori infection
Lasso di tempo: At the study visit during the 2-month data collection period
|
Association between caffeine consumption, measured in cups per day, and active H. pylori infection status determined using the structured lifestyle questionnaire, and active H. pylori infection status determined using the C14 urea breath test. |
At the study visit during the 2-month data collection period
|
|
Association between gastrointestinal symptoms and active Helicobacter pylori infection
Lasso di tempo: At the study visit during the 2-month data collection period
|
Association between the presence or absence of gastrointestinal symptoms, including dyspepsia, epigastric pain, fullness, heartburn, nausea, and bloating, and active H. pylori infection status determined using the C14 urea breath test. Gastrointestinal symptoms will be assessed using the structured clinical questionnaire. |
At the study visit during the 2-month data collection period
|
|
Association between recent medication use and active Helicobacter pylori infection
Lasso di tempo: At the study visit during the 2-month data collection period; medication use assessed during the preceding 4 weeks
|
Association between use of proton pump inhibitors, potassium-competitive acid blockers, NSAIDs, antibiotics, and probiotics during the preceding 4 weeks and active H. pylori infection status determined using the C14 urea breath test. Medication use will be assessed using the structured medication history questionnaire |
At the study visit during the 2-month data collection period; medication use assessed during the preceding 4 weeks
|
Collaboratori e investigatori
Sponsor
Sponsor
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- DINE-IN HP Study
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .